Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Prostatic Neoplasms 12Neoplasms 11Neuroendocrine Tumors 9Breast Neoplasms 9Lung Neoplasms 6Neoplasm Metastasis 4Multiple Myeloma 4Disease 4Uterine Cervical Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Mouth Neoplasms 2Lymphoma, Follicular 2Liver Neoplasms 2Leukemia 2Hypoxia 2Hodgkin Disease 2Glioma 2Esophageal Neoplasms 2Carcinoma, Neuroendocrine 2Brain Neoplasms 2

Interventions

Blood Specimen Collection 9Liquid Biopsy 4cabazitaxel 3Trastuzumab 3Surgical Procedures, Operative 3Propofol 3Bevacizumab 3Standard of Care 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Morphine 2Laparoscopy 2Folfox protocol 2Epirubicin 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2Anesthesia, General 2ribociclib 1pertuzumab 1osimertinib 1jinfukang 1eribulin 1Zoledronic Acid 1Vinorelbine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplastic Cells, Circulating × Positron Emission Tomography Computed Tomography × Clear all
NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

University of Wisconsin, Madison

Phase 2 Recruiting
8 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT03481101 2020-10-08

WHENII

Rigshospitalet, Denmark

Phase NA Unknown
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡